TD Cowen Lowers Teladoc Health (NYSE:TDOC) Price Target to $15.00

Teladoc Health (NYSE:TDOC) had its price target dropped by analysts at TD Cowen from $16.00 to $15.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has a “hold” rating on the health services provider’s stock. TD Cowen’s price objective suggests a potential upside of 15.30% from the stock’s current price.

TDOC has been the topic of a number of other research reports. SVB Leerink began coverage on shares of Teladoc Health in a research report on Monday, February 26th. They issued a “market perform” rating and a $17.00 price target on the stock. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a report on Friday. Cantor Fitzgerald started coverage on shares of Teladoc Health in a research report on Thursday, February 29th. They set an “overweight” rating and a $22.00 target price for the company. Leerink Partnrs reaffirmed a “market perform” rating on shares of Teladoc Health in a research report on Monday, February 26th. Finally, Barclays cut their price objective on Teladoc Health from $25.00 to $20.00 and set an “overweight” rating for the company in a research report on Friday. Eleven research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Teladoc Health presently has a consensus rating of “Hold” and an average price target of $19.67.

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $13.01 on Friday. The company has a current ratio of 3.54, a quick ratio of 3.47 and a debt-to-equity ratio of 0.66. Teladoc Health has a 1 year low of $12.65 and a 1 year high of $30.41. The firm has a fifty day moving average price of $14.85 and a 200 day moving average price of $17.72.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The company had revenue of $646.13 million for the quarter, compared to the consensus estimate of $637.31 million. Teladoc Health had a negative return on equity of 10.11% and a negative net margin of 8.90%. The business’s revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the company posted ($0.37) EPS. On average, equities analysts expect that Teladoc Health will post -1.06 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Teladoc Health news, EVP Andrew Turitz sold 6,190 shares of the business’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the sale, the executive vice president now owns 39,429 shares of the company’s stock, valued at approximately $572,509.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, insider Daniel Trencher sold 6,780 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $98,445.60. Following the completion of the transaction, the insider now owns 28,192 shares in the company, valued at approximately $409,347.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Andrew Turitz sold 6,190 shares of the company’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the sale, the executive vice president now directly owns 39,429 shares in the company, valued at approximately $572,509.08. The disclosure for this sale can be found here. Insiders sold a total of 135,441 shares of company stock valued at $2,038,251 over the last ninety days. 1.63% of the stock is owned by company insiders.

Hedge Funds Weigh In On Teladoc Health

Several institutional investors have recently added to or reduced their stakes in the company. Commonwealth Equity Services LLC increased its holdings in shares of Teladoc Health by 5.7% during the third quarter. Commonwealth Equity Services LLC now owns 80,934 shares of the health services provider’s stock worth $1,505,000 after buying an additional 4,344 shares in the last quarter. Robeco Institutional Asset Management B.V. grew its position in Teladoc Health by 49.4% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 453,861 shares of the health services provider’s stock worth $8,437,000 after acquiring an additional 149,976 shares during the last quarter. Raymond James & Associates boosted its stake in Teladoc Health by 0.9% in the third quarter. Raymond James & Associates now owns 228,238 shares of the health services provider’s stock worth $4,243,000 after purchasing an additional 2,029 shares in the last quarter. Mackenzie Financial Corp grew its holdings in shares of Teladoc Health by 83.7% during the third quarter. Mackenzie Financial Corp now owns 30,843 shares of the health services provider’s stock worth $570,000 after purchasing an additional 14,050 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its holdings in shares of Teladoc Health by 8.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 50,903 shares of the health services provider’s stock worth $946,000 after purchasing an additional 4,129 shares during the last quarter. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.